Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Research Shows Liposomal Vitamin C Makes Skin 33% Firmer

Published: Tuesday, February 25, 2014
Last Updated: Tuesday, February 25, 2014
Bookmark and Share
Altrient® C significantly improves skins elasticity in just 4 weeks.

Abundance & Health has announced positive results of a 4 week clinical trial investigating the anti-aging skin firming properties of their lead product Altrient® C, the world’s first liposomal vitamin C gel.

The results of the trial demonstrated that participants taking Altrient C had significantly improved their skin elasticity over the 4-week period of the clinical trial, compared to those taking the placebo. Participants using Altrient C had improved skin firmness and elasticity by 32.7 percent over the same period.

After just 14 days, skin firmness and elasticity had already improved by 15.1 percent (over 1 percent a day on average). The trial tested the general skin firming properties of Altrient C, rather than just those parts of the body that lotions are commonly applied to. 100 percent of participants reported that they would switch to Altrient C in favour of their current anti-aging skincare product.

“Skin elasticity is a critical part in the visual aging process, and thousands of years of research has so far provided limited results. This research has demonstrated a clear link between the skin aging process and vitamin C via dietary supplements,” said Jonathan Orchard, Director, Abundance & Health. “However, up to 85 percent of the vitamin C contained in tablets and powders is destroyed in the digestive system. Altrient C's vitamin C is encased in a tiny bubble of protective fatty acids. This safeguards the vitamin through the harsh digestive system and the body’s absorption barriers, into the bloodstream, where it is transported through the body. This is a unique vitamin C delivery mechanism, ensuring maximum benefits. This research has shown that skin elasticity is considerably improved by this unique delivery system, ensuring that up to 98 percent of the vitamin C is absorbed straight into the bloodstream, reaching cells in the most effective way.”

The placebo-controlled trial was conducted by Aspen Clinical Research, the clinical and cosmetic industry researchers. The trial involved 60 participants with non-firm aging skin aged between 31 and 65+. 50 percent took 3 sachets of Altrient C a day for 4 weeks and 50 percent taking a placebo. Participants’ skin firmness and elasticity were measured at three points through the trial by Cutometer MPA 580, the Courage + Khazaka electronic GmbH elasticity measurement device.

After 4 weeks, 100 percent of participants who consumed Altrient C reported an overall improvement in the skin. 50 percent noticed greater hydration. 43 percent thought they looked younger. 33 percent thought their skin appeared more nourished. 100 percent would change their current anti-aging routine by not just adding Altrient C to their skin regime, but replacing all products they currently use with Altrient C.

Abundance & Health plan to run a second clinical trial for a longer period, in order to measure a peak in the skins improvement. The second trial will determine how long improvements in skin elasticity will continue, as well as how much additional improvement can be measured.

“Skin ageing is a complex process involving genetic, hormonal and environmental factors,” said Dr Sanjay Rajpara, dermatologist and cosmetic skin doctor. “Formation of free oxygen radicals is widely accepted as a pivotal mechanism leading to skin ageing. The production of free radicals increases with ageing. Vitamin C is an important part of the body’s anti oxidative defence mechanism. Although there are some studies showing this benefit in vitro, there are not many showing direct effects of vitamin C in humans. This is a good quality study showing improvement in skin elasticity in human skin over a period of 4 weeks. This product has a potential to become one of the first line products for anti-ageing.”

“At Aspen Clinical Research, a leading expert in claim substantiation, we test thousands of products every year. We conducted a 4-week trial based upon industry standard techniques to assess the skin firming capabilities of an ingested dietary supplement, Altrient C,” said Danny McCamlie, Lead Clinical Scientist and Principal Investigator at Aspen Clinical. “We found that Altrient C caused an increase in skin firmness and skin elasticity under Cutometery assessments. With an increase of 15.1 percent and 32.7 percent in skin firmness, following 2 and 4 weeks respectively, Altrient C achieved results that, in our experience, some topically applied creams fail to achieve following 8 weeks of use.”

There were some results in addition to skin firmness. Of those taking Altrient C suffering from colds and flu, 36 percent recovered in 1-2 days, and 64 percent recovered in 3 - 4 days. This was in comparison to the placebo respondents where 82 percent took 5 - 6 days to recover. In addition, all of the subjects consuming Altrient C also reported a significant increase in their energy levels.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!